Home › Funds › Numerai GP LLC › INDV
Numerai GP LLC position in INDV
INDIVIOR PHARMACEUTICALS INC · Health Care
Numerai GP LLC reported holding 198,529 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$7.1M, representing 0.53% of its reported portfolio and ranking #32 among its reported holdings. Numerai GP LLC has disclosed INDV holdings in 2 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Numerai GP LLC's INDV position evolved
Numerai GP LLC first disclosed a stake in INDV in Q3 2025 at 33,149 shares (US$799K). The position peaked in Q3 2026 at 198,529 shares, worth US$7.1M. Across 2 filings, Numerai GP LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 198,529 shares valued at US$7.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 33.15K | $799.22K | New |
| Q3 2026 | 198.53K | $7.12M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INDV and 13F data
INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 49 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INDV
- OAKTREE CAPITAL MANAGEMENT LP 6.13M sh · $251.40M · Q2 2026
- Two Seas Capital LP 3.67M sh · $131.61M · Q3 2026
- Madison Avenue Partners, LP 2.87M sh · $117.94M · Q2 2026
- MANGROVE PARTNERS IM, LLC 2.68M sh · $109.83M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.65M sh · $67.65M · Q2 2026
- Jones Hill Capital LP 1.53M sh · $54.73M · Q3 2026
- Newtyn Management, LLC 1.31M sh · $53.58M · Q2 2026
- Soleus Capital Management, L.P. 1.06M sh · $43.66M · Q2 2026
- GENDELL JEFFREY L 1.15M sh · $41.10M · Q3 2026
- Claret Asset Management Corp 685.52K sh · $28.13M · Q2 2026
- Westchester Capital Management, LLC 775.86K sh · $27.81M · Q3 2026
- Divisadero Street Capital Management, LP 601.86K sh · $24.69M · Q2 2026
More on Numerai GP LLC
FAQ
How long has Numerai GP LLC held INDV?
Numerai GP LLC has disclosed INDV holdings in 2 of the last 5 reported quarters, going back to Q3 2025.
What is Numerai GP LLC's current position in INDV?
As of Q3 2026, Numerai GP LLC holds 198.53K shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $7.12M, representing 0.53% of its reported portfolio and ranking #32.
Has Numerai GP LLC been buying or selling INDV?
In the latest 13F filing (Q3 2026), Numerai GP LLC newly opened its position in INDV. The position peaked in Q3 2026 at 198.53K shares.
Which other funds hold INDV?
Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, Madison Avenue Partners, LP, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.